Other
Net Change in Cash
Regeneron Pharmaceuticals Net Change in Cash decreased by 125.1% to -$153.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 125.3%, from $604.00M to -$153.10M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
Detailed definition
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
Peer comparison
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
Metric ID:
net_change_in_cashHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $634.30M | $1.36B | $461.10M | $49.40M | $96.20M | $809.40M | -$1.98B | $210.50M | -$128.00M | -$681.60M | $83.60M | $604.00M | -$1.08B | $497.50M | $610.60M | -$153.10M |
| QoQ Change | — | +114.4% | -66.1% | -89.3% | +94.7% | +741.4% | -344.5% | +110.6% | -160.8% | -432.5% | +112.3% | +622.5% | -278.4% | +146.2% | +22.7% | -125.1% |
| YoY Change | — | — | — | -92.2% | -92.9% | +75.5% | <-999% | +118.8% | -115.8% | +65.6% | -60.3% | +571.9% | -58.1% | +495.1% | — | -125.3% |
Range-$1.98B – $1.36B
CAGR-31.5%
Avg YoY Growth-277.0%
Median YoY Growth-59.2%
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's net change in cash?
- Regeneron Pharmaceuticals (REGN) reported net change in cash of -$153.10M in Q1 2026.
- How has Regeneron Pharmaceuticals's net change in cash changed year-over-year?
- Regeneron Pharmaceuticals's net change in cash decreased by 125.3% year-over-year, from $604.00M to -$153.10M.
- What does net change in cash mean?
- The total change in the company's cash balance after accounting for all spending, earning, and investment activities.